\BOOKMARK [0][-]{chapter.1}{Beskrivelse og tekniske karakteristika for teknologien \(TEC\)}{}% 1
\BOOKMARK [1][-]{section.1.1}{Form\345l}{chapter.1}% 2
\BOOKMARK [1][-]{section.1.2}{HTA sp\370rgsm\345l}{chapter.1}% 3
\BOOKMARK [1][-]{section.1.3}{Metode}{chapter.1}% 4
\BOOKMARK [1][-]{section.1.4}{Teknologiens egenskaber}{chapter.1}% 5
\BOOKMARK [2][-]{subsection.1.4.1}{Anvendelsesomr\345de for QST}{section.1.4}% 6
\BOOKMARK [2][-]{subsection.1.4.2}{Unders\370gelse af PPT, TSP og CPM}{section.1.4}% 7
\BOOKMARK [1][-]{section.1.5}{Teknologiens begr\346nsninger}{chapter.1}% 8
\BOOKMARK [2][-]{subsection.1.5.1}{Begr\346nsende faktorer ved benyttelse af QST}{section.1.5}% 9
\BOOKMARK [1][-]{section.1.6}{Sammenligning med nuv\346rende metoder}{chapter.1}% 10
\BOOKMARK [2][-]{subsection.1.6.1}{Sammenspil mellem QST og klinisk vurdering}{section.1.6}% 11
\BOOKMARK [1][-]{section.1.7}{Delkonklusion}{chapter.1}% 12
\BOOKMARK [0][-]{chapter.2}{Klinisk effekt \(EFF\)}{}% 13
\BOOKMARK [1][-]{section.2.1}{Form\345l}{chapter.2}% 14
\BOOKMARK [1][-]{section.2.2}{HTA sp\370rgsm\345l}{chapter.2}% 15
\BOOKMARK [1][-]{section.2.3}{Metode}{chapter.2}% 16
\BOOKMARK [1][-]{section.2.4}{Statistisk effekt}{chapter.2}% 17
\BOOKMARK [2][-]{subsection.2.4.1}{QST-unders\370gelsernens statistiske styrke}{section.2.4}% 18
\BOOKMARK [1][-]{section.2.5}{N\370jagtighed}{chapter.2}% 19
\BOOKMARK [2][-]{subsection.2.5.1}{Patientgruppering p\345 baggrund af QST-resultater}{section.2.5}% 20
\BOOKMARK [2][-]{subsection.2.5.2}{Repeterbarhed for QST}{section.2.5}% 21
\BOOKMARK [1][-]{section.2.6}{Delkonklusion}{chapter.2}% 22
\BOOKMARK [0][-]{chapter.3}{Sikkerhed \(SAF\)}{}% 23
\BOOKMARK [1][-]{section.3.1}{Form\345l}{chapter.3}% 24
\BOOKMARK [1][-]{section.3.2}{HTA sp\370rgsm\345l}{chapter.3}% 25
\BOOKMARK [1][-]{section.3.3}{Metode}{chapter.3}% 26
\BOOKMARK [1][-]{section.3.4}{Patientsikkerhed}{chapter.3}% 27
\BOOKMARK [2][-]{subsection.3.4.1}{Sikkerhedsm\346ssige risici for patienter}{section.3.4}% 28
\BOOKMARK [1][-]{section.3.5}{Sikkerhedsforanstaltninger}{chapter.3}% 29
\BOOKMARK [1][-]{section.3.6}{Delkonklusion}{chapter.3}% 30
\BOOKMARK [0][-]{chapter.4}{Organisatoriske aspekter \(ORG\)}{}% 31
\BOOKMARK [0][-]{chapter.5}{Patient- og sociale aspekter \(SOC\)}{}% 32
\BOOKMARK [0][-]{chapter.6}{Etik \(ETH\)}{}% 33
\BOOKMARK [0][-]{chapter.7}{Juridiske aspekter \(LEG\)}{}% 34
\BOOKMARK [0][-]{chapter.8}{Omkostninger og \370konomisk evaluering \(ECO\)}{}% 35
\BOOKMARK [1][-]{section.8.1}{Form\345l}{chapter.8}% 36
\BOOKMARK [1][-]{section.8.2}{HTA sp\370rgsm\345l}{chapter.8}% 37
\BOOKMARK [1][-]{section.8.3}{Metode}{chapter.8}% 38
\BOOKMARK [2][-]{subsection.8.3.1}{Tilegnelse af \370konomisk viden om QST}{section.8.3}% 39
\BOOKMARK [1][-]{section.8.4}{Teknologiens effekt i forhold til omkostninger}{chapter.8}% 40
\BOOKMARK [2][-]{subsection.8.4.1}{Omkostninger ved implementering af QST}{section.8.4}% 41
\BOOKMARK [2][-]{subsection.8.4.2}{\330konomisk effekt ved implementering af QST}{section.8.4}% 42
\BOOKMARK [1][-]{section.8.5}{Ressourceudnyttelse}{chapter.8}% 43
\BOOKMARK [2][-]{subsection.8.5.1}{P\345virkning af Region Nordjyllands budget}{section.8.5}% 44
\BOOKMARK [1][-]{section.8.6}{Delkonklusion}{chapter.8}% 45
\BOOKMARK [0][-]{section*.20}{Litteratur}{}% 46
